Asia & Latin America Over-the-Counter Medicine Markets to Show Big Revenues, Reports Visiongain03 Aug 2012 • by Natalie Aster
Overall world revenue for OTC medicines will reach $80.7bn in 2014, the report forecasts. Brand line extensions and PLM will be important, stimulating revenue generation and unit sales worldwide.
From 2012 onwards, Rx-to-OTC switching and emerging healthcare markets - especially in Asia and Latin America - will produce high sales growth and large revenues. The pharma industry will benefit, as will consumers.
There are high levels of self-medication for many ailments. OTC treatments help consumers and healthcare providers reduce medical costs. From 2012 to 2022, the pharmaceutical industry will develop new OTC treatments. New formulations and generics will be important to the world market.
The new study “World OTC Pharmaceutical Market 2012-2022” by Visiongain investigates OTC (over-the-counter) pharmaceuticals: medicines sold without prescriptions. It lets assess projected sales at world market, therapeutic submarket, product and national level to 2022. You discover high growth potential there.
World OTC Pharmaceutical Market 2012-2022
Published: July, 2012
Price: US$ 2.642,00
There is forecasting of five world-level submarkets to 2022, finding potential revenues:
- Analgesics/pain relievers
- Gastrointestinal agents
- Dermatological treatments
- Smoking cessation products
- other relevant sales in consumer healthcare.
The analyses exclude vitamins, minerals and other nutritional products.
Also, how will eight leading products - including Tylenol, Nicorette, Panadol and Advil - perform from 2012 to 2022? This investigation gives business research and analysis with sales forecasts, including revenues for three leading OTC brand portfolios to 2022.
There are discussion of manufacturing and distribution of OTC pharmaceuticals. Also there are discussed regulations in main regions - the US, Europe, Japan and other places.
More information can be found in the report “World OTC Pharmaceutical Market 2012-2022” by Visiongain.
To order the report or ask for sample pages contact email@example.com